1. Home
  2. HCM vs KN Comparison

HCM vs KN Comparison

Compare HCM & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

N/A

Current Price

$14.98

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Logo Knowles Corporation

KN

Knowles Corporation

HOLD

Current Price

$23.32

Market Cap

2.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCM
KN
Founded
2000
1946
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HCM
KN
Price
$14.98
$23.32
Analyst Decision
Sell
Buy
Analyst Count
1
3
Target Price
$13.75
$22.33
AVG Volume (30 Days)
44.6K
765.6K
Earning Date
08-07-2025
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.53
0.48
Revenue
$602,197,000.00
$573,500,000.00
Revenue This Year
N/A
$9.26
Revenue Next Year
$15.54
$5.87
P/E Ratio
$5.58
$49.03
Revenue Growth
N/A
4.24
52 Week Low
$11.51
$12.19
52 Week High
$19.50
$24.54

Technical Indicators

Market Signals
Indicator
HCM
KN
Relative Strength Index (RSI) 64.80 59.13
Support Level $14.63 $21.90
Resistance Level $15.00 $23.60
Average True Range (ATR) 0.40 0.59
MACD 0.22 0.15
Stochastic Oscillator 83.57 86.94

Price Performance

Historical Comparison
HCM
KN

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

Share on Social Networks: